Home › Bids
› Early Stage Testing of Pharmacologic or Neuromodulatory Devi
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
This grant opportunity (PAR-25-183) from the NIH supports early-stage clinical trials (R33) for pharmacologic or neuromodulatory device-based interventions aimed at treating mental disorders. The funding is available under CFDA 93.242.
Want the full details?
Sign up free to see the agency name and the original bid posting link, plus contracting-officer contacts and AI response outlines. Every feature is free through December 31, 2026.